Today: 19 May 2026
Browse Category

NASDAQ:WGH 18 May 2026

Wellgistics Health Shares Jump 100% Ahead of Tuesday Earnings

Wellgistics Health Shares Jump 100% Ahead of Tuesday Earnings

Wellgistics Health shares jumped 108% to $0.1740 on Nasdaq Monday, with volume topping 614 million. The company withdrew preliminary proxy materials as it reviews potential strategic transactions. First-quarter results are due Tuesday after a late-filing notice for its 10-Q. Wellgistics recently announced a non-binding letter of intent to acquire WellCare Today for about $15 million.
18 May 2026
··

Stock Market Today

  • Five Stocks to Buy and Hold for Long-Term Wealth Building
    May 18, 2026, 7:43 PM EDT. Investors aiming for long-term wealth should focus on quality businesses suitable for 'buy and forget' strategies, holding through market cycles to allow compounding to maximize returns. Key traits include a strong economic moat, consistent earnings growth, and a commitment to long-term value creation. Leading examples are DBS Group, Southeast Asia's largest bank with a record S$22.9 billion income in FY2025 and a strong 17% return on equity in Q1 2026, outperforming peers OCBC and UOB. Another is ST Engineering, a global tech and defence firm backed by government contracts, boasting a robust order book of S$33.2 billion and planned dividend growth tied to profit increases. Both exemplify stability and growth potential for patient investors.

Latest articles

Agilysys Shares Rise After Earnings Beat

Agilysys Shares Rise After Earnings Beat

19 May 2026
Agilysys shares jumped 16.7% to $81.90 after hours Monday following record fiscal Q4 revenue of $82.9 million and a fiscal 2027 outlook above current sales. Net income for the quarter rose to $12.3 million, or 43 cents a share, from $3.9 million a year earlier. The stock outperformed a weaker tech sector, with the Nasdaq down 0.5%.
Regeneron stock sinks after cancer trial miss prompts selloff

Regeneron stock sinks after cancer trial miss prompts selloff

19 May 2026
Regeneron Pharmaceuticals shares fell 9.8% to $629.68 Monday after its late-stage melanoma drug trial with fianlimab failed to meet the main goal. The study did not show a statistically significant benefit over Merck’s Keytruda. At least 10 brokerages cut price targets. The decline outpaced broader market losses, with the Nasdaq down 0.5%.
Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

19 May 2026
Sunshine Biopharma shares surged as much as 516% before settling up 78% at $0.51 in heavy after-hours Nasdaq trading Monday, following a $6 million public offering priced at $0.50 per unit. More than 436 million shares changed hands, far exceeding the company’s 5 million shares outstanding. The deal includes 12 million units with warrants, raising dilution concerns. Closing is expected around May 19.

Popular

Why Plug Power Stock Is Falling Today After Its Hydrogen Rally

Why Plug Power Stock Is Falling Today After Its Hydrogen Rally

18 May 2026
Plug Power shares dropped 9.8% to $3.41 in late-morning trading Monday, erasing part of last week’s post-earnings rally. The company reported first-quarter revenue of $163.5 million and improved margins, but posted a net loss of $245.3 million. Investors remain concerned about cash burn and future dilution. Other hydrogen stocks also fell sharply.
Go toTop